Trabectedin derivative 2
Trabectedin derivative 2 is the derivative of Trabectedin. Trabectedin derivative 2 can be used for the research of cancer[1].
Product Specifications
CAS Number
[3056692-81-7]
UNSPSC
12352203
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Smiles
N#C[C@@H]([C@]1([H])CC2=CC(C)=C3OC)N([C@](CO4)([H])C5=C(OCO6)C6=C7C)[C@@]([C@@](N1C)([H])C2=C3O)([H])[C@@](SC[C@](C8=CC=C9N)(NCCC8=C9)C4=O)([H])C5=C7OC(C)=O
Molecular Formula
C39H41N5O8S
Molecular Weight
739.84
References & Citations
[1]Bin Zou, et al. Antibody-drug conjugates comprising trabectedin and lurbinectedin derivatives. WO2024186264A1. 2024-09-12.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15244206 1 Vial
Lentiviral mouse Frmd7 shRNA (UAS) - Lentiviral mouse Frmd7 shRNA (UAS) (100)
Ask
View Details R9915-10D-ML405 100 µL
RUNX2 (S533) (Runt-related Transcription Factor 2, Core-binding Factor Subunit alpha-1, CBF-alpha-1, Acute Myeloid Leukemia 3 Protein, Oncogene AML-3, Polyomavirus Enhancer-binding Protein 2 alpha A Subunit, PEBP2-alpha A, PEA2-alpha A, SL3-3 Enhancer Factor 1 alpha A Subunit, SL3/AKV Core-binding Factor alpha A Subunit, Osteoblast-specific Transcription Factor 2, OSF-2, AML3, CBFA1, OSF2, PEBP2A) (MaxLight 405) discontinued
Ask
View Details